Clinical evaluation of early marker in diagnosing rheumatoid arthritis

Medical Journal of Wuhan University

Volumn 26, Issue 4, 2005, Pages 529-532

  Cheng, Pengfei ^a   Liu, Yuanrui ^a   Chen, Shu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Anti cyclic Citrullinated Peptide Antibody; Anti keratin Antibody; Anti pernuclear Factor; Anti RA33; Rheumatoid Arthritis; Rheumatoid Factor

Indexed keywords

BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; KERATIN ANTIBODY; PERNUCLEAR FACTOR ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

EID: 33747003770     PISSN: 16718852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Vincent C, Simon M, Sebbag M, et al. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol, 1998,25:838
2. Menard HA, Lapointe E, Rochdi M, et al. Insights into rheumatoid arthritis derived from the Sa immune sytem. Arthritis Res, 2000,2:429
3. Nicola B, Giovanni M, Elio S, et al. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem, 2001,47:1 089
4. Bas S, Perneger TV, Seitz M, et al. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology, 2002,41(7):809